IPO Pipeline: Avaada Electro, Grand Housing, Sonaselection P...
19 Apr 2026
Synopsis
Windlas Biotech approved a Rs 47 crore share buyback at Rs 1,000 per share via the tender route, with April 24 set as the record date. The move covers 2.23% equity and excludes promoters. Shares rose 2% following the announcement, reflecting positive investor sentiment toward the capital return plan.
Choose your reason below and click on the Report button. This will alert our moderators to take action
Name
Reason for reporting:
Foul languageSlanderousInciting hatred against a certain communityOthers
Your Reason has been Reported to the admin.